Xie et al. (63) found that METTL3 could induce the downregulation of BATF2 expression in gastric cancer (GC) because METTL3 catalyzes the m6A modification of BATF2 mRNA, which reduces mRNA stability. Here, METTL3 is linked to gastric cancer.